Who Paid My Doc Search
Menu
Product Program year 2019 Source: CMS Open Payments

Erwinaze

Drug Oncology

NDC 57902-249-05

Open in the dashboard

General payments

$88,149

59 payments

Research payments

$0

0 payments

Through program year 2019, $88,149 in general payments and $0 in research payments were reported against Erwinaze (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2019 General $88,149 59

Breakdown

Who paid General payments · program year 2019
  1. Jazz Pharmaceuticals Inc. $88,149 59 payments
Top recipients General payments · program year 2019
  1. Ut Md Anderson Cancer Center Teaching hospital · TX $75,000 85% · 1 payment
  2. Scott Howard Pediatric Hematology-Oncology · Memphis, TN $4,453 5% · 4 payments
  3. Amer Zeidan Hematology & Oncology · New Haven, CT $3,180 4% · 1 payment
  4. Stuart Winter Pediatric Hematology-Oncology · Albuquerque, NM $963 1% · 1 payment
  5. Stanton Goldman Pediatric Hematology-Oncology · Dallas, TX $793 <1% · 2 payments

The top 5 of 55 recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Pediatric Hematology-Oncology Pediatrics $8,515 65% · 35 practitioners
  2. Hematology & Oncology Internal Medicine $3,234 25% · 4 practitioners
  3. Medical Oncology Internal Medicine $550 4% · 1 practitioner
  4. Internal Medicine $500 4% · 1 practitioner
  5. Nephrology Internal Medicine $124 <1% · 1 practitioner

The top 5 of 14 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Texas $76,489 87% · 8 recipients
  2. Tennessee $4,453 5% · 1 recipient
  3. Connecticut $3,180 4% · 1 recipient
  4. Minnesota $963 1% · 1 recipient
  5. Maryland $675 <1% · 2 recipients

The top 5 of 19 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

Records

59 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record